New test will analyze DNA to predict risk of prostate cancer

01/16/2008 | NYTimes.com

A team of U.S. scientists found that men with a combination of common and minor variations in five DNA regions are more likely to develop prostate cancer than those who had none of the variants. ProActive Genetics is expected to develop a test that could help doctors predict a man's risk of getting the disease via DNA analysis of saliva or blood samples.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC